US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Pharmaceuticals Etf

66.79

-1.1100-1.63%

Pre-market: 66.790.00000.00%04:00 EDT

Volume:126.69K

Turnover:8.45M

Market Cap:581.09M

PE:25.87

High:67.70

Open:67.70

Low:66.31

Close:67.90

52wk High:74.35

52wk Low:45.80

Shares:8.70M

Float Shares:8.70M

Volume Ratio:0.66

T/O Rate:1.46%

Dividend:0.34

Dividend Rate:0.51%

EPS(TTM):2.58

EPS(LYR):-0.1280

ROE:42.40%

ROA:0.26%

PB:1.36

PE(LYR):-521.73

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030

Structure weakness ‘disconnected’ from underlying data, says Jefferies

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/XPH"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"XPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","market":"US","secType":"STK","nameCN":"Spdr S&P Pharmaceuticals Etf","latestPrice":66.79,"timestamp":1789502400000,"preClose":67.9,"halted":0,"volume":126687,"hourTrading":{"tag":"盘前","latestPrice":66.79,"preClose":66.79,"latestTime":"04:00 EDT","volume":3,"amount":200.37,"timestamp":1789545606493,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.01634756995581737,"floatShares":8700270,"shares":8700270,"eps":2.581957,"marketStatus":"Pre-Mkt","change":-1.11,"latestTime":"09-16 06:56:13 EDT","open":67.7,"high":67.7,"low":66.31,"amount":8449816.40019,"amplitude":0.020471,"askPrice":74.29,"askSize":100,"bidPrice":57.87,"bidSize":100,"shortable":3,"etf":1,"ttmEps":2.581957,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":66.79,"sharesOutstanding":5750270,"nav":67.914259,"aum":580685253.4,"dividendRate":0.005091,"bidAskSpread":0.001356,"preHourTrading":{"tag":"盘前","latestPrice":66.79,"preClose":66.79,"latestTime":"04:00 EDT","volume":3,"amount":200.37,"timestamp":1789545606493,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":66.79,"preClose":66.79,"latestTime":"19:30 EDT","volume":18,"amount":1202.22,"timestamp":1789515006707,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6613678726986589,"impliedVol":0.2084,"impliedVolPercentile":0.932},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XPH\",,,,,undefined,":{"symbol":"XPH","floatShares":8700270,"roa":"0.26%","roe":"42.40%","lyrEps":-0.128016,"volumeRatio":0.6613678726986589,"shares":8700270,"dividePrice":0.34,"high":67.7,"amplitude":0.020471,"preClose":67.9,"low":66.31,"week52Low":45.8,"pbRate":"1.36","psRate":"265.24","week52High":74.345,"institutionHeld":0,"latestPrice":66.79,"eps":2.581957,"divideRate":0.005091,"volume":126687,"delay":0,"ttmEps":2.581957,"open":67.7,"prevYearClose":56.01,"prevWeekClose":67.51,"prevMonthClose":70.62,"prevQuarterClose":66.27,"fiveDayClose":70.38,"twentyDayClose":70.42,"sixtyDayClose":61.04},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XPH\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XPH","amount":0.059045,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2026-03-23","symbol":"XPH","amount":0.060954,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-25","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-25"},{"date":"2025-12-22","symbol":"XPH","amount":0.113024,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XPH","amount":0.102634,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XPH","amount":0.095872,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XPH\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.059917,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.091273,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.026956,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.085023,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.07227,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XPH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XPH\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1188259168","title":"Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14","url":"https://stock-news.laohu8.com/highlight/detail?id=1188259168","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188259168?lang=en_us&edition=fundamental","pubTime":"2026-09-11 17:50","pubTimestamp":1789120228,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that the drug registration application for its self-developed denosumab biosimilar, HLX14 (recombinant anti-RANKL fully human...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","BK4588","BK0012","02196","LU2272731865.HKD","LU2473716301.USD","BK0188","BK0183","BK0060","LU2322448791.USD","LU2322448957.HKD","LU1992135399.USD","BK0175","BK1593","LU2272731782.SGD","600196","XPH","BK0096","LU2272731600.USD","BK0239","BK0028","IE00B5TLWC47.USD","BK1191","IBB","BK1515","PPH","BK0187","BK4585","LU1992135472.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107437767","title":"Henlius CEO Zhu Jun: Systematic Globalization Aims for Long-Term Gains, Innovative Drug Revenue Set to Surpass Biosimilars by 2030","url":"https://stock-news.laohu8.com/highlight/detail?id=1107437767","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107437767?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:11","pubTimestamp":1788959461,"startTime":"0","endTime":"0","summary":"During the 2026 Yabuli Forum Summer Annual Meeting, Henlius (02696.HK) Executive Director and CEO Dr. Zhu Jun outlined the company's \"systematic globalization\" strategy in an in-depth conversation,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2322448791.USD","159992","LU2272731600.USD","IBBQ","IE00B5TLWC47.USD","BK1574","HK0000165453.HKD","LU2322448957.HKD","06978","LU1992135399.USD","LU2473716301.USD","HK0000306701.USD","LU2272731865.HKD","BK4588","HK0000320223.HKD","BK4585","PPH","LU2272731782.SGD","LNGR","HK0000306685.HKD","HK0000320264.USD","IBB","MEDX","XPH","02696","LU1992135472.HKD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377632","title":"Structure weakness ‘disconnected’ from underlying data, says Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377632","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377632?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:00","pubTimestamp":1788897615,"startTime":"0","endTime":"0","summary":"After Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates, ACCG-2671 and aleniglipron, Jefferies see...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-weakness-disconnected-from-underlying-data-says-jefferies-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNCR","FHLC","IDNA","GDOC","AZNH","MEDX","SYNB","SURI","MNTL","TBXU","IEIH","BME","WDNA","GNMX","LLYX","PBE","HRTS","SBIO","NVIB","FBT","LFSC","PJP","MEDI","FTXH","MDTX","APXH","GNOM","IBRN","GSKH","BBP","XPH","PTH","RSPH","CURE","FXH","JDOC","JHMH","IBBQ","PINK","PSIL","IBBJ","IBB","MRNY","PBPH","BBH","HYLG","PSCH","BIB","CANC","GPCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665637847","title":"Structure Therapeutics reports ACCG-2671, aleniglipron trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2665637847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665637847?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:36","pubTimestamp":1788871007,"startTime":"0","endTime":"0","summary":"Structure Therapeutics (GPCR) reported clinical trial results from its two lead product candidates: ACCG-2671, an oral, non-peptide, small molecule...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/structure-therapeutics-reports-accg-2671-aleniglipron-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNOM","MEDI","GNMX","APXH","PBPH","PBE","PSCH","WDNA","IBB","IDNA","MNTL","FBT","NVIB","GPCR","MEDX","XPH","PSIL","GSKH","FTXH","SYNB","FXH","AZNH","IBBJ","MRNY","BME","JDOC","JHMH","GDOC","MDTX","PJP","BBP","RSPH","HRTS","SURI","IBRN","HYLG","LENZ","BIB","BBH","PINK","TBXU","IBBQ","SBIO","FHLC","CURE","CANC","LLYX","CNCR","PTH","LFSC"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XPH\",params:#limit:6,delay:false,,,undefined,":[]}}